Stock Analysis on Net

Intuitive Surgical Inc. (NASDAQ:ISRG)

$24.99

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Intuitive Surgical Inc., consolidated cash flow statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net income
Depreciation and loss on disposal of property, plant, and equipment
Amortization of intangible and other assets
Accretion of discounts, amortization of premiums, and (gains) losses on investments, net
Gain on sale of business and assets
Deferred income taxes
Share-based compensation expense
Accounts receivable
Inventory
Prepaids and other assets
Accounts payable
Accrued compensation and employee benefits
Deferred revenue
Other liabilities
Changes in operating assets and liabilities, net of effects of acquisitions
Adjustments to reconcile net income to net cash provided by operating activities
Net cash provided by operating activities
Purchase of investments
Proceeds from sales of investments
Proceeds from maturities of investments
Proceeds from sale of assets
Purchase of property, plant, and equipment
Acquisition of business, net of cash, and intellectual property and other investing activities
Net cash (used in) provided by investing activities
Proceeds from issuance of common stock relating to employee stock plans
Taxes paid related to net share settlement of equity awards
Repurchase of common stock
Cash dividends paid by joint venture to noncontrolling interest
Payment of deferred purchase consideration
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Net increase (decrease) in cash, cash equivalents, and restricted cash

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The financial trajectory of the organization is characterized by a sustained expansion in profitability and operating cash flow, punctuated by periodic volatility in working capital and aggressive capital allocation strategies. Net income demonstrates a long-term upward trend, rising from 435.2 million USD in March 2021 to 826 million USD by March 2026, reflecting a significant scaling of the core business operations.

Operating Cash Flow and Profitability
Net cash provided by operating activities exhibits overall growth, peaking at 911.9 million USD in March 2026. While net income has grown steadily, the conversion to cash has been influenced by fluctuations in operating assets and liabilities. A recurring pattern of significant cash outflows is observed in the "Changes in operating assets and liabilities" line item, particularly in March 2024 and March 2026, which suggests cyclical surges in working capital requirements.
Working Capital Dynamics
Inventory represents a consistent and increasing drain on cash, with outflows expanding from 41.2 million USD in early 2021 to 266.6 million USD by March 2026. This indicates a strategic build-up of stock to support growth or mitigate supply chain risks. Accounts receivable and prepaids also show high volatility, contributing to the quarterly variance in net cash provided by operations.
Investment and Capital Expenditure
Capital expenditures for property, plant, and equipment have trended upward, reaching a peak of 435.5 million USD in December 2023, suggesting a period of intense infrastructure or capacity expansion. Investment activities are characterized by high volatility due to the active management of a securities portfolio, with substantial purchases of investments frequently offset by proceeds from maturities.
Financing and Shareholder Returns
The financing strategy has shifted toward aggressive capital return to shareholders. While early periods showed modest activity, there is a marked increase in the repurchase of common stock, most notably a 1.9 billion USD outflow in September 2025 and 1.1 billion USD in March 2026. This indicates a shift in priority toward enhancing shareholder value through buybacks as the company generates excess cash.
Non-Cash Adjustments
Share-based compensation expense has grown linearly, doubling from approximately 103.2 million USD in March 2021 to 209.5 million USD by March 2026. This suggests an increasing reliance on equity-based incentives to attract and retain talent as the organization grows.

In summary, the company maintains a strong cash-generative profile. The transition from an investment-heavy phase to an aggressive share repurchase phase, coupled with rising net income, indicates a mature financial position capable of funding both internal growth and significant shareholder distributions.